Brought to you by:
VEITH 2021: Researchers present ex vivo demonstration of fluoroscopy-free complex AAA stent placement
“I think this represents the beginning of the end of an era where we have to use lead to perform these procedures.” Those were the words delivered by Gustavo Oderich, MD, professor and chief of vascular and endovascular surgery at…
VEITH 2021: Two-year follow-up data from EVAS2 IDE study delivered
The confirmatory EVAS2 clinical study to evaluate the safety and effectiveness of Endologix’s Nellix endovascular aneurysm sealing system (EVAS) for the treatment of infrarenal abdominal aortic aneurysms (AAAs) contains positive two-year follow-up data, the leading investigator has revealed. A first…
Julie A. Freischlag becomes president of American College of Surgeons
Newly installed American College of Surgeons (ACS) President Julie A. Freischlag, MD, called for her fellow surgeons to apply the principles that underpin enhanced recovery as medicine begins to emerge from the COVID-19 pandemic. The former Society for Vascular Surgery…
Endologix launches randomized study of Alto EVAR device
Endologix today announced that the first patient has been enrolled in the company’s JAGUAR study to compare outcomes for the company’s Alto abdominal stent graft system to other commercially available endovascular aneurysm repair (EVAR) devices for the treatment of abdominal…
Females were 30% less likely to undergo surgery for PAD, national database study finds
A review of more than 1 million patients receiving vascular surgery over a 16-year period identified significant sex-related disparities in the treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD)—with females 30% less likely to undergo surgery in…
First patient enrolled in AAA-SHAPE Netherlands study
Shape Memory Medical has announced the initiation of AAA-SHAPE Netherlands, the company’s prospective, multicenter early feasibility study of the Impede-FX RapidFill device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). The Dutch study’s first procedure…
Special session on diversity enters VAM agenda
Over the course of more than a year, diversity, equity and inclusion (DEI) have been brought into sharp focus by a compendium of events inside and outside of medicine. As U.S. society has reckoned with the socioeconomic and cultural consequences…
Just 16% of US centers in VQI offer SVS guideline-compliant open repair for AAA, new study finds
There is a stark downward trend in the number of U.S. centers in the Vascular Quality Initiative (VQI) that meet the Society for Vascular Surgery (SVS) clinical practice guidelines for open repair of abdominal aortic aneurysm (AAA), new research to…
Endologix receives FDA Breakthrough Device designation for ChEVAS system
Endologix announced the company’s ChEVAS (chimney endovascular aneurysm sealing) system has been granted a Breakthrough Device designation from the Food and Drug Administration (FDA). The ChEVAS system is an investigational endovascular abdominal aortic aneurysm (AAA) sealing therapy designed to combine the Nellix 3.5 endograft…
Large study shows drop in AAA mortality ‘at faster rate than ever’
According to a new, population-based analysis, abdominal aortic aneurysm (AAA) mortality has continued to decline and “at a faster rate than ever” in the second decade of the 21st century. Authors C. Y. Maximilian Png, MD, a vascular surgery resident…